Encoded Therapeutics raises $275 million in Series F financing to advance ETX101 through pivotal development and accelerate its precision genetic medicines neurology pipeline.
Amount Raised
$275 Million
Round Type
Series F
South San FranciscoBiotechnologyHealth CareTherapeuticsInvestors
Description
Encoded Therapeutics has successfully raised $275 million in its Series F financing round. The funds will be utilized to advance its lead product, ETX101, and accelerate the development of its precision genetic medicines for neurology. This financing is a significant step forward in the company's mission to deliver innovative treatments. The investment showcases strong confidence in the company's pipeline and growth potential.
Quick answer
Encoded Therapeutics raised $275 Million in a Series F round, dated September 9, 2026. Investors: Softbank Vision Fund, RTW Investments, Janus Henderson and GV. Encoded Therapeutics is based in South San Francisco, California, United States.
- How much did Encoded Therapeutics raise?
- Encoded Therapeutics raised $275 Million in a Series F round on September 9, 2026.
- Who invested in Encoded Therapeutics?
- Softbank Vision Fund, RTW Investments, Janus Henderson and GV are named as investors in this round.
- What does Encoded Therapeutics do?
- Encoded Therapeutics is a clinical-stage biotechnology company focused on developing genetic medicines for severe central nervous system (CNS) disorders.
- Where is Encoded Therapeutics based and how big is it?
- Encoded Therapeutics is based in South San Francisco, California, United States. Fundz records about 210 employees.
- Who are the decision-makers at Encoded Therapeutics?
- Fundz holds 3 contacts at Encoded Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Encoded Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Quanta Therapeutics raised an undisclosed amount (Series D) on October 24, 2026.
- Pathos AI raised $237M (Series E) on October 23, 2026.
- Trior raised $25M (Series C) on October 23, 2026.
- Arctic Therapeutics raised $22M on October 21, 2026.
- Disc raised $422M (Post-IPO Equity) on October 20, 2026.
- Nouscom raised $135M (Series D) on October 19, 2026.
Who to call at Encoded Therapeutics, and when
A new round usually means Encoded Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Encoded Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Encoded Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Encoded Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Encoded Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Encoded Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.